This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Chemours (CC) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Chemours (CC) delivered earnings and revenue surprises of 58.70% and 14.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Scotts Miracle-Gro (SMG) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
ScottsMiracle-Gro's (SMG) Q2 performance is likely to have benefited from strength in the U.S. Consumer segment and cost savings.
Andersons (ANDE) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Andersons's (ANDE) Q1 performance is likely to reflect benefits from strong demand and high commodity and fertilizer prices.
TimkenSteel (TMST) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
TimkenSteel (TMST) is expected to have benefited, in the first quarter, from higher demand in industrial and energy end markets.
DuPont (DD) Gears Up for Q1 Earnings: What's in the Offing?
by Zacks Equity Research
DuPont (DD) is likely to have benefited from strong demand and productivity actions. However, higher raw material and logistics costs are expected to have hurt its Q1 results.
Why Chemours (CC) Might Surprise This Earnings Season
by Zacks Equity Research
Chemours (CC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Will Higher Prices Benefit Nutrien (NTR) in Q1 Earnings?
by Zacks Equity Research
Higher prices aided by strong demand and tight supply are likely to have driven Nutrien's (NTR) sales and margins in the first quarter.
FMC Corp (FMC) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
FMC Corp's (FMC) first-quarter performance is likely to reflect increased demand and pricing amid headwinds from higher input costs resulting from supply chain disruptions.
Westlake (WLK) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Westlake's (WLK) Q1 performance is likely to have benefited from higher demand trends for polyethylene and PVC resin.
Will Higher Selling Prices Drive Mosaic's (MOS) Q1 Earnings?
by Zacks Equity Research
Profitability across Mosaic's (MOS) Phosphates and Potash segments is expected to have boosted by higher average selling prices in Q1.
Intrepid Potash (IPI) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Intrepid Potash (IPI) is likely to have benefited from strong demand and higher net realized sales price per ton for its potash and Trio products in Q1.
Nutrien (NTR) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Nutrien's (NTR) Q1 results are likely to have benefited from solid demand and higher prices for fertilizers, aided by the underlying strength in global agriculture markets.
Chemours (CC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Chemours (CC) closed at $32.64, marking a +1.15% move from the previous day.
LyondellBasell (LYB) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
LyondellBasell's (LYB) Q1 performance is likely to have benefited from strong consumer-driven demand and favorable market trends.
Chemours (CC) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Chemours' (CC) first-quarter performance is likely to reflect the increasing adoption of Opteon refrigerants and the benefits of cost-cutting measures.
Mosaic (MOS) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Mosaic (MOS) is likely to have benefited from strong demand and prices for phosphate and potash in the first quarter.
Huntsman (HUN) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Huntsman's (HUN) Q1 performance is likely to have benefited from health demand and prices for MDI amid headwinds from higher input and logistics costs.
Celanese (CE) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Celanese's (CE) Q1 performance is likely to have benefited from productivity actions, investments in high-return organic projects and strategic acquisitions.
Linde (LIN) Gears Up to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Higher industrial production is likely to have aided Linde (LIN) in Q1.
Chemours (CC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Chemours (CC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chemours (CC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Chemours (CC) closed at $35.65 in the latest trading session, marking a +0.85% move from the prior day.
Chemours (CC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Chemours (CC) closed at $32.44 in the latest trading session, marking a +0.43% move from the prior day.
Northern Technologies (NTIC) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Northern Technologies (NTIC) delivered earnings and revenue surprises of -33.33% and 4.84%, respectively, for the quarter ended February 2022. Do the numbers hold clues to what lies ahead for the stock?
Chemours (CC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Chemours (CC) closed at $32.32 in the latest trading session, marking a +0.19% move from the prior day.
Chemours (CC) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.